Moolec Science implements 15-for-1 share consolidation effective January 5

Moolec Science SA (NASDAQ: MLEC) announced that its board of directors has set the effective date and final ratio for a previously approved share consolidation. The consolidation will take effect at 8:00 a.m. Eastern Time on January 5, 2026.

The consolidation ratio is 15-for-1, meaning every 15 ordinary shares with a par value of $0.10 each will become one ordinary share with a par value of $1.50 each. The number of issued and outstanding ordinary shares will decrease from 10,891,761 shares to approximately 726,118 shares.

No fractional shares will be issued to shareholders. Any fractional shares resulting from the consolidation will be rounded up to the nearest whole share. The company stated that except for fractional share adjustments, the consolidation will not have a dilutive effect on shareholders.

The new shares will begin trading on the Nasdaq Capital Market on January 5, 2026, under CUSIP number G6223S 125. The consolidation is intended to help the company regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share for continued listing, as outlined in Nasdaq Listing Rule 5550(a)(2).

Continental Stock Transfer & Trust Company, located at 1 State Street 30th Floor, New York, NY 10004-1571, is serving as the transfer agent for the share consolidation.

Moolec Science is a food ingredient company that engineers plants and microbes to produce animal proteins and nutritional oils. The company operates in the United States, Europe and South America.

You May Also Be Interested In

• NVIDIA reports 9.3% passive stake in Nebius
• U.S. to impose 50% tariff on most Canadian goods, including USMCA
• Inotiv exits Chapter 11 with $326M in debt reduced